Skip to content
Abierto
Menu

Award notice, first published as special notice

PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

HT941024P0210

Defense Health Agency (Dha), Defense Health Agency HCD West. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Advanced Accelerator Applications USA Inc.

$32,426.31 on the award notice, August 18, 2024, contract HT941024P0210

Description

As published on SAM.gov.

PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) Injections.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Advanced Accelerator Applications USA Inc.
UEI
JNM4NBNHFE66
CAGE
3PTH3
Vendor location
Millburn, NJ
Contract
HT941024P0210, purchase order
Obligated
$227,236.17
Actions
1 between August 16, 2024 and August 16, 2024
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Lutetium Lu 177 Vipivotide Tetraxetan
Match
award number HT941024P0210 equals the contract number; same awarding office HT9410 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 12, 2024

    Special notice

    Radiopharmaceutical PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

    Due August 15, 2024 at 1:00 PM EDT. SAM.gov, notice dcc5cc06e4364bdda403ffbc482f4cd3

  2. August 16, 2024

    Award notice

    Awarded to ADVANCED ACCELERATOR APPLICATIONS USA Inc. Millburn for $32,426. SAM.gov, notice 439f8271c7854f348bd4ec6562afa8ed

Points of contact

Also open from this buyer